Skip to main content

Table 3 Clinical pharmacist interventions identified using PCNE v9.00 (N = 463)

From: Drug-related problems in hospitalized patients with chronic kidney diseases and clinical pharmacist interventions

DRPs

Detailed Classification

N (%)

Intervention domain (total 463)

  
 

I1

 

At prescriber level

234(50.54)

  

I1.3

Intervention proposed to prescriber

48(20.51)

  

I1.4

Intervention discussed with prescriber

186(79.49)

 

I3

 

At drug level

229(49.46)

  

I3.1

Drug changed to

45(19.65)

  

I3.2

Dosage changed to

57(24.89)

  

I3.3

Formulation changed to

7(3.06)

  

I3.4

Instructions for use changed to

14(6.11)

  

I3.5

Drug paused or stopped

38(16.59)

  

I3.6

Drug started

68(29.69)

Acceptance domain (total 463)

  
 

A1

 

Intervention accepted by patient or prescriber

396(85.53)

  

A1.1

Intervention accepted and fully implemented

387(97.73)

  

A1.2

Intervention accepted, implemented partially

8(2.02)

  

A1.3

Intervention accepted but unimplemented

1(0.25)

 

A2

 

Intervention not accepted

67(14.47)

  

A2.1

Intervention unaccepted: not feasible

4(5.97)

  

A2.2

Intervention unaccepted: no agreement

61(91.04)

  

A2.4

Intervention unaccepted: unknown reason

2(2.99)

  1. PCNE: Pharmaceutical Care Network Europe; DRPs: drug-related problems